picotamide has been researched along with Myeloproliferative Disorders in 2 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders." | 1.29 | Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. ( Carpi, A; Ferretti, A; Nicolini, A; Sagripanti, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagripanti, A | 1 |
| Ferretti, A | 1 |
| Nicolini, A | 1 |
| Carpi, A | 1 |
| Rafanelli, D | 1 |
| Grossi, A | 1 |
| Vannucchi, AM | 1 |
| Cinotti, S | 1 |
| Morfini, M | 1 |
| Ferrini, PR | 1 |
2 other studies available for picotamide and Myeloproliferative Disorders
| Article | Year |
|---|---|
Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Hemorrhage; | 1996 |
The effect of picotamide on platelet function in patients with myeloproliferative disorders.
Topics: Humans; Myeloproliferative Disorders; Phthalic Acids; Pilot Projects; Platelet Aggregation Inhibitor | 1990 |